États-Unis · Actualité générale · NBC News

Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial

Publié par NBC News · États-Unis il y a 1 h

Moderna and Merck’s personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared with standard treatment in a trial.

Lire l'article complet sur NBC News Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.nbcnews.com)

Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial

À lire aussi

Bangladesh’s climate migrants are arriving in cities unprepared to protect them

DeSantis gifts Trump gold coin with engraved image of him ‘flipping the bird’

CHAOS INC.: Who's who in the global mayhem network? Communists, Antifa, agitators in the red-green alliance.

Vance could be a major Category 3 hurricane Friday as it nears Mexico

Registered sex offender, 29, busted trying to enroll in high school as teen girl — and it’s not his first time

Trump administration stopped sharing evidence in Good and Pretti killings, Minnesota officials say

Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial

Partager

À lire aussi

Bangladesh’s climate migrants are arriving in cities unprepared to protect them

DeSantis gifts Trump gold coin with engraved image of him ‘flipping the bird’

CHAOS INC.: Who's who in the global mayhem network? Communists, Antifa, agitators in the red-green alliance.

Vance could be a major Category 3 hurricane Friday as it nears Mexico

Registered sex offender, 29, busted trying to enroll in high school as teen girl — and it’s not his first time

Trump administration stopped sharing evidence in Good and Pretti killings, Minnesota officials say